Innova Captab [INNOVACAP] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Innova Captab Ltd. wins in 11 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Innova Captab Ltd. | Gujarat Themis Biosyn Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.20 | 73.73 | Innova Captab Ltd. |
| Price-to-Book Ratio | 4.05 | 13.36 | Innova Captab Ltd. |
| Debt-to-Equity Ratio | 32.95 | 27.04 | Gujarat Themis Biosyn Ltd. |
| PEG Ratio | 1.33 | -17.55 | Innova Captab Ltd. |
| EV/EBITDA | 20.49 | 52.76 | Innova Captab Ltd. |
| Profit Margin (TTM) | 8.85% | 29.99% | Gujarat Themis Biosyn Ltd. |
| Operating Margin (TTM) | 12.88% | 40.16% | Gujarat Themis Biosyn Ltd. |
| EBITDA Margin (TTM) | 12.88% | 40.16% | Gujarat Themis Biosyn Ltd. |
| Return on Equity | 13.37% | 19.64% | Gujarat Themis Biosyn Ltd. |
| Return on Assets (TTM) | 8.12% | 16.19% | Gujarat Themis Biosyn Ltd. |
| Free Cash Flow (TTM) | $-1.09B | $-251.22M | Gujarat Themis Biosyn Ltd. |
| Dividend Yield | 0.30% | 0.17% | Innova Captab Ltd. |
| 1-Year Return | 3.87% | 15.75% | Gujarat Themis Biosyn Ltd. |
| Price-to-Sales Ratio (TTM) | 2.76 | 22.23 | Innova Captab Ltd. |
| Enterprise Value | $43.41B | $36.09B | Innova Captab Ltd. |
| EV/Revenue Ratio | 2.90 | 22.65 | Innova Captab Ltd. |
| Gross Profit Margin (TTM) | 35.19% | 83.29% | Gujarat Themis Biosyn Ltd. |
| Revenue per Share (TTM) | $262 | $15 | Innova Captab Ltd. |
| Earnings per Share (Diluted) | $23.16 | $4.40 | Innova Captab Ltd. |
| Beta (Stock Volatility) | -0.33 | -0.17 | Innova Captab Ltd. |
Innova Captab Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Innova Captab Ltd. | 0.58% | 8.95% | 10.45% | 34.08% | 34.58% | 28.37% |
| Gujarat Themis Biosyn Ltd. | -0.57% | -4.89% | 4.00% | 38.98% | -1.40% | -12.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Innova Captab Ltd. | 3.87% | 74.08% | 74.08% | 74.08% | 74.08% | 74.08% |
| Gujarat Themis Biosyn Ltd. | 15.75% | 76.92% | 76.92% | 76.92% | 76.92% | 76.92% |
Performance & Financial Health Analysis: Innova Captab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | INNOVACAP | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹41.43B | ₹35.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 578,151 | 79,452 |
| 90 Day Avg. Volume | 217,693 | 106,446 |
| Last Close | ₹947.95 | ₹385.10 |
| 52 Week Range | ₹622.00 - ₹978.00 | ₹225.05 - ₹479.00 |
| % from 52W High | -3.07% | -19.60% |
| All-Time High | ₹1,260.00 (Jan 06, 2025) | ₹479.00 (Oct 27, 2025) |
| % from All-Time High | -24.77% | -19.60% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.42% | 0.10% |
| Quarterly Earnings Growth | 0.23% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.30% |
| Operating Margin (TTM) | 0.13% | 0.40% |
| Return on Equity (TTM) | 0.13% | 0.20% |
| Debt to Equity (MRQ) | 32.95 | 27.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹178.28 | ₹24.29 |
| Cash per Share (MRQ) | ₹10.22 | ₹0.92 |
| Operating Cash Flow (TTM) | ₹282.88M | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹1.28B | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.30% | 0.17% |
| Last 12-Month Dividend | ₹2.00 | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Innova Captab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | INNOVACAP (Apr 24, 2026) | GUJTHEM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.20 | 73.73 |
| Forward P/E | 21.90 | N/A |
| PEG Ratio | 1.33 | -17.55 |
| Price to Sales (TTM) | 2.76 | 22.23 |
| Price to Book (MRQ) | 4.05 | 13.36 |
| Market Capitalization | ||
| Market Capitalization | ₹41.43B | ₹35.41B |
| Enterprise Value | ₹43.41B | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.90 | 22.65 |
| Enterprise to EBITDA | 20.49 | 52.76 |
| Risk & Other Metrics | ||
| Beta | -0.33 | -0.17 |
| Book Value per Share (MRQ) | ₹178.28 | ₹24.29 |
Financial Statements Comparison: Innova Captab Ltd. vs Gujarat Themis Biosyn Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | INNOVACAP (2025) | GUJTHEM (2025) |
|---|---|---|
| Revenue/Sales | 12.34B | 1.51B |
| Cost of Goods Sold | 8.38B | 318.78M |
| COGS % of Revenue | 67.9% | 21.1% |
| Gross Profit | 3.96B | 1.19B |
| Gross Margin | 32.1% | 78.9% |
| Research & Development | N/A | 34.37M |
| Operating Income (EBIT) | 1.65B | 642.49M |
| Operating Margin | 13.4% | 42.6% |
| EBITDA | 2.00B | 713.04M |
| EBITDA Margin | 16.2% | 47.3% |
| Pre-Tax Income | 1.71B | 655.38M |
| Pre-Tax Income % of Revenue | 13.9% | 43.5% |
| Income Tax | 427.58M | 167.66M |
| Income Tax % of Revenue | 3.5% | 11.1% |
| Net Income (Profit) | 1.28B | 487.72M |
| Profit Margin | 10.4% | 32.3% |
Balance Sheet & Liquidity Metrics
| Metric | INNOVACAP (2025) | GUJTHEM (2025) |
|---|---|---|
| Cash & Equivalents | 155.19M | 116.94M |
| Total Current Assets | 7.03B | 519.73M |
| Total Current Assets % of Revenue | 57.0% | 34.5% |
| Total Current Liabilities | 3.53B | 205.60M |
| Total Current Liabilities % of Revenue | 28.6% | 13.6% |
| Long-Term Debt | 2.45B | 296.36M |
| Long-Term Debt % of Revenue | 19.8% | 19.7% |
| Total Shareholders Equity | 9.59B | 2.48B |
| Retained Earnings | 4.53B | 2.37B |
| Retained Earnings % of Revenue | 36.7% | 157.4% |
| Property, Plant & Equipment | 442.93M | 411.30M |
Cash Flow Statement Comparison
| Metric | INNOVACAP (2025) | GUJTHEM (2025) |
|---|---|---|
| Operating Cash Flow | 282.88M | 970.68M |
| Operating Cash Flow % of Revenue | 2.3% | 64.4% |
| Capital Expenditures | -1.72B | -1.16B |
| Free Cash Flow | -1.09B | -251.22M |
| FCF Margin | -8.8% | -16.7% |
| Debt Repayment | -114.03M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INNOVACAP | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 57.22M | 108.97M |
| Float Shares | 15.91M | 29.52M |
| % Held by Insiders | 72.19% | 71.98% |
| % Held by Institutions | 19.22% | 1.18% |
| % Held by Public | 8.59% | 26.84% |
Dividend Analysis & Yield Comparison: Innova Captab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | INNOVACAP | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹0.67 |
| Last 12-Month Dividend Yield | 0.30% | 0.17% |
| 3-Year Avg Annual Dividend | ₹0.67 | ₹0.22 |
| 3-Year Avg Dividend Yield | 0.30% | 0.17% |
| 3-Year Total Dividends | ₹2.00 | ₹0.67 |
| Ex-Dividend Date | Jan 30, 2026 | Sep 04, 2025 |